Search - tctmd.com

Displaying 161 - 180 of 189

Sort: Relevancy | Date

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

News Daily News

Strategy Safely Rules Out PE Using Clinical Criteria in Low-Risk Patients

Michael O'Riordan

February 14, 2018

Featured Fellow: Matthew Czarny, MD

News Featured Fellow

Matthew Czarny, MD

Yael L. Maxwell

February 13, 2018

Could NOACs Have a Role for Secondary Prevention After STEMI?

News Daily News

Could NOACs Have a Role for Secondary Prevention After STEMI?

February 08, 2018

Neurological Prognosis Affects Survival Benefit of Early Intervention After Cardiac Arrest

News Daily News

Neurological Prognosis Affects Survival Benefit of Early Intervention After Cardiac Arrest

February 08, 2018

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

News Daily News

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

February 07, 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

News Conference News ISET 2018

Revascularization or Medical Therapy? CREST-2 Aims to Get It Right in Asymptomatic Carotid Disease

February 07, 2018

Risk Scores Combined With Lower Troponin Cut Points May Help Refine Rule-Out Tests for Chest Pain

News Daily News

Risk Scores Combined With Lower Troponin Cut Points May Help Refine Rule-Out Tests for Chest Pain

February 05, 2018

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

News Daily News

Existing Neurocognitive Deficits Cloud Interpretation of Post-TAVR Changes: SENTINEL Analysis

February 05, 2018

Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH?

News Conference News ISC 2018

Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH?

January 30, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

News Conference News ISC 2018

More Evidence Rivaroxaban May Carry Higher Bleeding Risk Than Other NOACs

January 27, 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

News Conference News ISC 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

January 25, 2018

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

News Daily News

Sixfold Higher Risk of Acute MI in the Week After Flu Diagnosis

Michael O'Riordan

January 24, 2018

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

January 22, 2018

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

News Daily News

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

January 17, 2018

Next-Day Discharge Safe Following Minimalist TAVR, Study Shows

News Daily News

Next-Day Discharge Safe Following Minimalist TAVR, Study Shows

Michael O'Riordan

January 16, 2018

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

News Daily News

Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed

Michael O'Riordan

January 10, 2018

Shifts in Stroke Score Over Time Help Hone Risk Prediction

News Daily News

Shifts in Stroke Score Over Time Help Hone Risk Prediction

January 10, 2018

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.